Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

epigallocatechin gallate 2XENP 1595 2Etanercept 2Ascorbic Acid 2salicylsalicylic acid 1microcrystalline cellulose 1ginger extract 1dapagliflozin 1cytisine 1Tablets 1Sulindac 1Spirometry 1Specimen Handling 1Sodium Salicylate 1Radiotherapy, Conformal 1Pregabalin 1Omeprazole 1Losartan 1Ketorolac 1Interleukin 1 Receptor Antagonist Protein 1Infliximab 1Hematologic Tests 1Diet Therapy 1Atorvastatin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Inflammation × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡